Prelude Therapeutics, Inc. (PRLD)
4.52
-0.18
(-3.83%)
USD |
NASDAQ |
Apr 27, 15:29
Prelude Therapeutics Price : 4.52 for April 27, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Incyte Corp. | 95.89 |
| Niagen Bioscience, Inc. | 4.915 |
| Immunome, Inc. | 23.79 |
| Sana Biotechnology, Inc. | 3.235 |
| Moderna, Inc. | 48.93 |
Price Related Metrics
| PS Ratio | 27.09 |
| Price to Book Value | 4.149 |
| Earnings Yield | -29.95% |
| Market Cap | 284.77M |